These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date, and reported results 2004-000414-39 A randomised, double-blind, placebo-controlled, parallel group, multicenter study to evaluate the long-term efficacy and safety of Norspan® versus placebo Norspan in subjects with chronic, moderate to... bad-data
Listed as ongoing, but also has a completion date and reported results 2004-003752-19 A Randomized, Double-blind, Placebo- and Active-controlled, Double-dummy, Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged-release Tablets in Subjects with Mod... 2007-07-23 bad-data
Reported results 2005-001791-13 An open-label, randomized, parallel-group, monocenter study to evaluate safety and efficacy of Oxycodone Hydrochloride administered orally (CR) and intravenously in patients with total hip endoprosthe... 2007-07-03 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-002398-57 A randomized, double-blind, parallel-group, multicenter study to demonstrate improvement in symptoms of constipation in subjects with non-malignant pain taking oxycodone equivalent of >= 20 mg/day and... 2008-04-25 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-003510-15 A randomised, double-blind, double-dummy, parallel-group multicenter study to demonstrate improvement in symptoms of constipation in subjects with non-malignant pain taking oxycodone equivalent of 60 ... 2008-07-14 bad-data
Reported results 2006-001888-40 A phase II prospective non-comparative multicenter clinical trial to determine the efficacy and safety of intrathecal liposomal cytarabine (DepoCyte®) in preventing CNS-relapse in patients with aggres... 2008-02-01 due-trials
Reported results 2006-003233-32 A randomized, open, controlled parallel group, multi-center study to evaluate the efficacy and safety of Norspan versus Tiparol Retard in subjects with chronic, moderate to severe osteoarthritis pain ... 2007-08-30 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-005926-22 An open, randomised, parallel group, multicentre study to compare the efficacy and safety of FlutiForm pMDI vs Seretide pMDI in adult subjects with mild to moderate-severe persistent, reversible asthm... 2008-03-13 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-005928-16 An open, randomised, parallel group, multicentre study to compare the efficacy and safety of FlutiForm pMDI vs Seretide pMDI in paediatric subjects with mild to moderate persistent, reversible asthma. 2008-06-27 bad-data
Ongoing 2007-000179-41 Intrathecal chemotherapy with liposomal ara-C (Depocyte) in leptomeningeal metastases of solid tumors: a phase III study not-yet-due
Listed as ongoing, but also has a completion date and reported results 2007-001313-42 A randomised, double-blind, active-controlled, double-dummy, parallel group study to determine the safety and efficacy of oxycodone / naloxone prolonged release tablets in subjects with moderate to se... 2010-08-17 bad-data
Reported results 2007-001633-34 A double blind, double dummy, randomised, multicentre, four arm parallel group study to assess the efficacy and safety of FlutiForm™ pMDI 250/10 µg (2 puffs bid) vs Fluticasone pMDI 250 µg (2 puffs bi... 2009-08-27 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-001634-13 An open, randomised, parallel group, multicentre study to compare the efficacy and safety of FlutiFormTM pMDI compared with Fluticasone pMDI plus Formoterol DPI in adolescent and adult subjects with m... 2008-04-01 bad-data
Reported results 2007-005101-21 An open, multi-centre, non-comparative observational study to assess the safety and tolerability of Oxycodone hydrochloride injection 50 mg/mL as a subcutaneous infusion in subjects with severe cancer... 2009-05-29 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-005922-62 An exploratory, randomised, active-controlled, double-blind, double-dummy, parallel group pilot study to determine the ability of oxycodone/naloxone prolonged release tablets (OXN) to reduce the numbe... 2008-12-26 bad-data
Ongoing, reported early 2008-001026-14 An open study with OXN to evaluate the patient preference for pain treatment with respect to quality of life after WHO step I or step II analgesics for patients with moderate to severe non-malignant p... not-yet-due
Reported results 2008-002185-60 RANDOMISED, CONTROLLED CLINICAL STUDY REGARDING THE FEASIBILITY OF CONVERTING OPIATE DEPENDENTS FROM METHADONE SUBSTITUTES TO SLOW RELEASE MORPHINE SULPHATE (SEVRE-LONG®) 2011-06-29 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-002219-42 A Phase I/II Pharmacokinetic Study of Intravenous and Oral Forodesine in Children with Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non-Hodgkin’s Lymphom... 2010-10-14 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-002428-27 A multi-centre, open-label, single therapy, dose ranging study to characterise the pharmacokinetics and tolerability of BTDS 5-20 µg/h in children who require opioid analgesia for moderate to severe m... 2012-11-22 bad-data
Reported results 2008-002670-36 A randomised, double-blind, double-dummy, parallel-group multicentre study to demonstrate non-inferiority in pain and locomotor function and improvement in symptoms of constipation in subjects with mo... 2010-08-02 due-trials
Not reported 2008-003566-26 An exploratory, randomised, parallel-group, open-label, multicentre study to assess the post-operative management of moderate to severe pain in patients who underwent laparoscopic cholecystectomy, rec... 2009-03-13 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-005315-18 A confirmatory, placebo-controlled, randomised, double-blind, single-dummy, parallel group, ratio-finding study in constipated pain patients to establish an optimal hydromorphone – naloxone ratio with... 2012-01-12 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-005815-17 An exploratory, randomised, double-blind, single-dummy, placebo controlled, parallel group study to demonstrate the analgesic efficacy of oxycodone/naloxone prolonged release tablets (OXN PR) in addit... 2010-04-02 bad-data
Reported results 2009-009873-87 A double-blind, randomised, incomplete block, crossover, placebo-controlled, dose-response study to assess bronchial hyperresponsiveness and airway inflammation effects of FlutiForm® pMDI low and high... 2010-07-14 due-trials
Reported results 2009-011107-23 A randomised, double-blind, placebo-controlled, parallel-group, multicenter study to demonstrate improvement of symptoms of RLS in subjects with moderate to severe idiopathic RLS with daytime symptoms... 2012-04-24 due-trials
Ongoing, reported early 2009-012051-20 Study of the efficacy of prolonged release oxycodone/naloxone (OXN PR), compared to prolonged release oxycodone (Oxy PR), for the reduction of the intensity of opioid-induced constipation symptoms in ... not-yet-due
Reported results 2009-016957-17 A randomised, double-blind, parallel group multicenter study to demonstrate non-inferiority of the analgesic efficacy of oxycodone/naloxone 10/5 or 20/10 mg prolonged release tablets (OXN PR) BID comp... 2010-10-17 due-trials
Reported results 2009-017223-25 A double blind, double dummy, randomised, multicentre, two arm parallel group study to assess the efficacy and safety of FlutiForm® pMDI 125/5 µg (2 puffs bid) vs Symbicort® Turbohaler® 200/6 µg (2 pu... 2010-11-15 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-018118-21 An exploratory, randomised, double-blind, placebo-controlled, parallel group, pilot study to assess the analgesic efficacy of oxycodone/naloxone prolonged release tablets (OXN PR) compared to placebo ... 2013-03-25 bad-data
Reported results 2010-020748-37 An open label, multi-centre, prospective age-group-controlled study to evaluate efficacy and safety of buprenorphine transdermal patches in subjects with chronic, moderate to severe osteoarthritis pai... 2012-08-20 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-021995-27 A randomised, double-blind, double-dummy, parallel-group multicenter study to demonstrate improvement in symptoms of constipation and non-inferiority in analgesic efficacy in subjects with non-maligna... 2014-08-18 bad-data
Ongoing 2010-022102-41 A randomised, open label, multi-centre, Phase III study to investigate the efficacy of bendamustine compared to treatment of physician`s choice in the treatment of subjects with indolent Non-Hodgkin L... not-yet-due
Reported results 2010-024635-16 A double-blind, double dummy randomised, parallel group, multicentre study to compare the efficacy and safety of Flutiform pMDI with fluticasone pMDI and with Seretide pMDI in paediatric subjects aged... 2013-09-19 due-trials
Reported results 2011-000939-86 An open-label single site single dose pilotstudy using mannitol challenge test with the purpose to explore treatment with fixed dose combinations in adult subjects with asthma in primary care in Swede... 2012-04-17 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-002353-57 A randomised, multi-centre, double-blind, active-controlled, parallel group study to assess the efficacy and safety of modified release prednisone (Lodotra®) compared to immediate release prednisone (... 2014-03-25 bad-data
Listed as ongoing, but also has a completion date and reported results 2011-002901-31 A multicentre, double-blind, randomised, placebo controlled study to determine the efficacy and tolerability of OXN PR for the treatment of severe Parkinson's disease associated pain 2013-11-05 bad-data
Reported results 2012-001772-11 An exploratory, double-blind, double-dummy, randomised, 2-period, crossover, Phase IIa study to assess the influence of oxycodone/naloxone prolonged-release tablets (OXN PR) and oxycodone prolonged-re... 2015-02-17 due-trials
Listed as ongoing, but also has a completion date and reported results 2012-004162-17 A randomised, double-blind, double dummy, parallel group study comparing Fluticasone propionate / formoterol fumarate (flutiform®) 250/10 mcg (2 puffs BID) and flutiform® 125/5 mcg (2 puffs BID) versu... 2016-05-04 bad-data
Reported results 2013-000180-81 A single-arm, open-label, multicentre, non-randomised, study to assess the effect and tolerability of standardised laxative therapy (SLT) for the reversal of opioid-induced constipation (OIC) in subj... 2014-08-27 due-trials
Reported results 2013-004719-32 A single (assessor) - blind, randomised, three-period, cross-over study to compare the safety of flutiform® pMDI, fluticasone pMDI and beclometasone Autohaler® in paediatric subjects aged 5 to less ... 2014-06-11 due-trials
Listed as ongoing, but also has a completion date and reported results 2013-004888-31 A randomised, double-blind, double-dummy, cross-over multicenter study to demonstrate equivalence in analgesic efficacy and bowel function taking oxycodone equivalents of 120 and 160 mg per day as ach... 2016-08-03 bad-data
Listed as ongoing, but also has a completion date and reported results 2014-004564-38 A randomised, open label, two-period, cross-over, multi-centre study to compare correct inhaler handling of fluticasone/ formoterol breath-actuated inhaler (K-haler®) with that of Symbicort® Turbohale... 2017-07-04 bad-data
Ongoing 2014-004904-31 An open-label, multicentre, phase IV study to investigate the infliximab serum concentration of Remsima™ (infliximab biosimilar) after switching from Remicade (infliximab) in subjects with Crohn’s Dis... not-yet-due
Completed, report not yet due 2015-000801-38 A two-arm, randomised, assessor-blind, parallel group study to evaluate the effect of fluticasone/formoterol breath actuated inhaler (BAI) and Relvar Ellipta DPI on ventilation heterogeneity in subjec... 2017-08-14 not-yet-due
Not reported 2015-002046-31 A randomised, single blind, cross-over study to compare a fixed dose combination of fluticasone propionate / formoterol fumarate (fluticasone /formoterol breath actuated inhaler (BAI)) with a fixed d... 2016-11-07 due-trials
Completed, report not yet due 2016-000592-24 A Randomized, Double-Blind, Multicenter, Placebo- and active Comparator-Controlled Study to evaluate Efficacy and Safety of MR308 in the Treatment of Acute Pain After Third Molar Tooth Extraction (STA... 2018-01-04 not-yet-due
Listed as ongoing, but also has a completion date 2016-000593-38 A Randomized, Double-Blind, Multicenter, Placebo- and active Comparator-Controlled Study to evaluate Efficacy and Safety of MR308 in the Treatment of Acute Pain After Abdominal Hysterectomy Surgery un... 2018-06-29 bad-data
Ongoing 2017-000338-70 A phase IIIb open randomized clinical trial to compare pain relief between methoxyflurane and standard of care for treating patients with trauma pain in Spanish emergency units. not-yet-due
Ongoing 2017-001565-25 Efficacy and safety of methoxyflurane vaporized (PENTHROX®) in the treatment of acute trauma pain in pre-hospital setting and in the emergency department in Italy: a multicentre, randomized, controlle... not-yet-due
Ongoing 2017-003767-35 A randomised, double-blind, parallel group study comparing patient controlled analgesia with Penthrox® (methoxyflurane) versus placebo during colonoscopy not-yet-due